Literature DB >> 9601522

Production of HIV-1 by human B cells infected in vitro: characterization of an EBV genome-negative B cell line chronically synthetizing a low level of HIV-1 after infection.

L Fritsch1, V Marechal, V Schneider, C Barthet, W Rozenbaum, M Moisan-Coppey, J Coppey, J C Nicolas.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) has tropism for helper T lymphocytes and cells of the monocyte/ macrophage lineages. HIV-1 can also infect other cell types, including B cells. We show here that 10% of fresh circulating B cells from HIV-1-seronegative donors (i) express the CD4 receptor and CCR5 and CXCR4, two recently described coreceptors for HIV-1 and (ii) are permissive to HIV-1 with de novo proviral DNA integration following ex vivo infection by either SI (syncytium-inducing) or NSI (non-syncytium-inducing) isolates. To get further information on the interaction between HIV and B cells, the susceptibility of several EBV-positive or -negative B cell lines to infection by SI and NSI isolates was checked. Following infection of an EBV- CD4+ CXCR4+ CCR5- B cell line (DG75) by an SI HIV-1 isolate, we obtained a cell line which chronically produced low-level infectious HIV-1 for 2 years (HIV-DG75). Immunocytochemical data, combined with in situ PCR data, established that HIV-DG75 cells consist of at least three populations uninfected cells, infected virus-producing cells, and infected but nonproducing cells. Moreover, HIV-DG75 cells which express p24 antigen do not go into apoptosis, contrary to T lymphocytes. We infer from these results that B cells could constitute a reservoir of infectious virus in infected patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9601522     DOI: 10.1006/viro.1998.9120

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Experimental infection with Schistosoma mansoni in CCR5-deficient mice is associated with increased disease severity, as CCR5 plays a role in controlling granulomatous inflammation.

Authors:  Adriano L S Souza; Patrícia R S Souza; Cíntia A Pereira; Adriana Fernandes; Rodrigo Guabiraba; Remo C Russo; Leda Q Vieira; Ary Corrêa; Mauro M Teixeira; Deborah Negrão-Corrêa
Journal:  Infect Immun       Date:  2011-01-24       Impact factor: 3.441

2.  Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.

Authors:  T S Hyun; C Subramanian; M A Cotter; R A Thomas; E S Robertson
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  CD40-Mediated induction of CD4 and CXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: potential role of B lymphocytes as a viral reservoir.

Authors:  S Moir; R Lapointe; A Malaspina; M Ostrowski; C E Cole; T W Chun; J Adelsberger; M Baseler; P Hwu; A S Fauci
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

4.  The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein.

Authors:  A Puri; P Hug; K Jernigan; J Barchi; H Y Kim; J Hamilton; J Wiels; G J Murray; R O Brady; R Blumenthal
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 5.  Feline immunodeficiency virus latency.

Authors:  Samantha J McDonnel; Ellen E Sparger; Brian G Murphy
Journal:  Retrovirology       Date:  2013-07-06       Impact factor: 4.602

6.  EBV renders B cells susceptible to HIV-1 in humanized mice.

Authors:  Donal McHugh; Renier Myburgh; Nicole Caduff; Michael Spohn; Yik Lim Kok; Christian W Keller; Anita Murer; Bithi Chatterjee; Julia Rühl; Christine Engelmann; Obinna Chijioke; Isaak Quast; Mohaned Shilaih; Victoria P Strouvelle; Kathrin Neumann; Thomas Menter; Stephan Dirnhofer; Janice Kp Lam; Kwai F Hui; Simon Bredl; Erika Schlaepfer; Silvia Sorce; Andrea Zbinden; Riccarda Capaul; Jan D Lünemann; Adriano Aguzzi; Alan Ks Chiang; Werner Kempf; Alexandra Trkola; Karin J Metzner; Markus G Manz; Adam Grundhoff; Roberto F Speck; Christian Münz
Journal:  Life Sci Alliance       Date:  2020-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.